The Administrator announces the suspension of Crypto.com as a CF Constituent Exchange for the following indices:
The suspension follows Crypto.com's cessation of support for Orchid (OXT) on April 18th, 2026. Accordingly, Crypto.com was formally suspended as a CF Constituent Exchange on April 24th, 2026.
Questions or queries regarding this process and decision should be directed to [email protected].
Any complaints regarding this process and decision can be made confidentially by writing to [email protected].
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
Digital assets traded mixed over the past week, with AVAX +1.5%, SOL +1.3%, and XRP -2.1%. Meanwhile, BVXS implied vol. fell to 37.31 as realized vol. compressed faster to 21.92. The CF Broad Cap Index (Free Float Market Cap Weight) eased 0.24%, leaving it 17.3% lower YTD.

CF Benchmarks
The market pulled back hard at -5.65%, the worst weekly drop of 2026. Growth and Value were the only positive factors, with fundamentals leading during the drawdown. Downside Beta fell, deviating from its pattern of resilience in earlier drawdowns.

Mark Pilipczuk
The Administrator can now confirm it will implement all proposed changes to the CME CF Bitcoin Volatility Index - Real Time methodology.

CF Benchmarks
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.